3 Drugs That Could Make-or-Break AbbVie Post author:Sam Post published:February 11, 2018 Post category:BioPharma A look at three drug approvals of vital importance to the company this year. Source: BioSpace You Might Also Like Astellas Takes Out Belgium Biotech in Deal Worth $853 Million April 2, 2017 Massachusetts' Selecta Banks $50 Million June 25, 2017 This Little-Known $12 Billion SoCal Startup Wants to Cure Baldness and Smooth Out Your Wrinkles April 2, 2017
This Little-Known $12 Billion SoCal Startup Wants to Cure Baldness and Smooth Out Your Wrinkles April 2, 2017
